Buscar resultados de ensayos clínicos

Patrocinado por

Keratoconjunctivitis - 40 Studies Found

Estado Estudiar
Completed Nombre del estudio: A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
Condición: Keratoconjunctivitis Sicca
Fecha: 2012-11-21
Intervenciones:
  • Drug: R348 Ophthalmic Solution, 0.2%

Completed Nombre del estudio: Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months
Condición:
  • Vernal Keratoconjunctivitis
  • Healthy Children

Fecha: 2013-11-25
Intervenciones: Procedure: Cytokins assay in tears
Completed Nombre del estudio: Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Condición:
  • Keratoconjunctivitis
  • Conjunctivitis

Fecha: 2007-12-03
Intervenciones: Drug: FK506 Ophthalmic suspension Other Name: tacrol
Completed Nombre del estudio: A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
Condición: Keratoconjunctivitis Sicca
Fecha: 2014-05-06
Intervenciones: Drug: Retaine™
Completed Nombre del estudio: Study of Rebamipide Eye Drops to Treat Dry Eye
Condición: Keratoconjunctivitis Sicca
Fecha: 2005-09-12
Intervenciones: Drug: Rebamipide
  • OPC as a
    • Terminated Nombre del estudio: Omega-3 Fatty Acid Supplements and Dry Eye
    Condición: Keratoconjunctivitis Sicca
    Fecha: 2010-09-30
    Intervenciones:
    • Dietary Supplement: Omega-3 Fatty Acid

    Completed Nombre del estudio: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
    Condición: Keratoconjunctivitis Sicca
    Fecha: 2015-12-16
    Intervenciones:
    • Drug: 1% Tavilermide Ophthalmic Solution

    Completed Nombre del estudio: Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
    Condición: Keratoconjunctivitis Sicca
    Fecha: 2002-05-18
    Intervenciones: Drug: INS365 Ophthalmic Solution
    Completed Nombre del estudio: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
    Condición: Keratoconjunctivitis Sicca
    Fecha: 2016-01-20
    Intervenciones:
    • Drug: 1% Tavilermide Ophthalmic Solution

    Completed Nombre del estudio: TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
    Condición: Keratoconjunctivitis Sicca
    Fecha: 2009-02-18
    <<< Previous | Next >>>